Infections and Vasculitis

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 549-557

  Tervaert, Jan Willem Cohen ^a   Stegeman, Coen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882863965     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50043-0     Document Type: Chapter

References (40)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
2. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990, 33:1065-1067.
3. Hagelskjaer KL, Prag J Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis 2000, 31:524-532.
4. Feigl D, Feigl A, Edwards JE Mycotic aneurysms of the aortic root. A pathologic study of 20 cases. Chest 1986, 90:553-557.
5. Hsu RB, Tsay YG, Wang SS, Chu SH Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 2002, 36:746-750.
6. Peng SL Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 2002, 31:228-247.
7. Duffy J, Lidsky MD, Sharp JT, Davis JS, Person DA, Hollinger FB, Min KW Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) 1976, 55:19-37.
8. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74:238-253.
9. Trepo C, Guillevin L Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001, 16:269-274.
10. Agnello V The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997, 19:111-129.
11. Agnello V, Abel G Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997, 40:2007-2015.
12. D'Amico G Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998, 54:650-671.
13. Cohen Tervaert JW, Stegeman CA, Kallenberg CG Standard therapeutic regiments for vasculitis. Disease Modifying Therapy in Vasculitides 2001, 21-40. Birkhauser. C.G. Kallenberg, J.W. Cohen Tervaert (Eds.).
14. Calabrese LH, Estes M, Yen-Lieberman B, Proffitt MR, Tubbs R, Fishleder AJ, Levin KH Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum 1989, 32:569-576.
15. Chetty R Vasculitides associated with HIV infection. J Clin Pathol 2001, 54:275-278.
16. Mandell BF, Calabrese LH Infections and systemic vasculitis. Curr Opin Rheumatol 1998, 10:51-57.
17. Ellis RW Infection and coronary heart disease. J Med Microbiol 1997, 46:535-539.
18. Tanaka S, Toh Y, Mori R, Komori K, Okadome K, Sugimachi K Possible role of cytomegalovirus in the pathogenesis of inflammatory aortic diseases: a preliminary report. J Vasc Surg 1992, 16:274-279.
19. Hendrix MG, Daemen M, Bruggeman CA Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991, 138:563-567.
20. Sissons JG, Carmichael AJ, McKinney N, Sinclair JH, Wills MR Human cytomegalovirus and immunopathology. Springer Semin Immunopathol 2002, 24:169-185.
21. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000, 342:635-645.
22. Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH The patterns of varicella zoster virus encephalitis. Hum Pathol 1996, 27:927-938.
23. Weyand CM, Goronzy JJ Medium- and large-vessel vasculitis. N Engl J Med 2003, 349:160-169.
24. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999, 42:1255-1258.
25. Wagner AD, Gerard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, Zeidler H Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000, 43:1543-1551.
26. Regan MJ, Wood BJ, Hsieh YH, Theodore ML, Quinn TC, Hellmann DB, Green WR, Gaydos CA, Stone JH Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum 2002, 46:1056-1060.
27. Helweg-Larsen J, Tarp B, Obel N, Baslund B No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxf) 2002, 41:445-449.
28. Somer T, Finegold SM Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995, 20:1010-1036.
29. Cohen Tervaert JW, Popa ER, Bos NA The role of superantigens in vasculitis. Curr Opin Rheumatol 1999, 11:24-33.
30. Cohen Tervaert JW, Popa ER, Brons RH Staphylococcal aureus, superantigens and vasculitis. Clin Exp Immunol 2000, 120(suppl. 1):6-7.
31. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994, 120:12-17.
32. Popa ER, Tervaert JW The relation between Staphylococcus aureus and Wegener's granulomatosis: current knowledge and future directions. Intern Med 2003, 42:771-780.
33. Cohen Tervaert JW, Stegeman CA, Kallenberg CG Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Nephrol Hypertens 2001, 10:211-217.
34. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CG Trimethoprim-sulfamethoxazole (co-tri-moxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996, 335:16-20.
35. Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, Speck SH, Virgin HW Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 1997, 3:1346-1353.
36. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest 2001, 107:R15-R22.
37. Trepo CG, Zucherman AJ, Bird RC, Prince AM The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 1974, 27:863-868.
38. Michalak T Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol 1978, 90:619-632.
39. Brons RH, Kallenberg CG, Cohen Tervaert JW Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?. Rheum Dis Clin North Am 2001, 27:833-848.
40. Benoist C, Mathis D Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?. Nat Immunol 2001, 2:797-801.